Carol Zoltowski
No más puestos en curso
Perfil
Carol Zoltowski worked as a Senior Director of Regulatory Affairs at Shaman Pharmaceuticals, Inc. and Anesiva, Inc. She then became the Vice President of Regulatory Affairs at VIVUS, Inc. and Senior Program Manager & Head of Regulatory Affairs at Syntex (USA), Inc. She also worked as a Principal at Roche Bioscience and Vice President of Regulatory Affairs at Aimmune Therapeutics, Inc. Her most recent position was as Senior Vice President of Regulatory Affairs & Quality at Jasper Therapeutics, Inc. Zoltowski holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Seton Hill University.
Antiguos cargos conocidos de Carol Zoltowski.
| Empresas | Cargo | Fin |
|---|---|---|
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Corporate Officer/Principal | - |
| JASPER THERAPEUTICS, INC. | Consejero General | - |
Syntex (USA), Inc.
 Syntex (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA. | Consejero General | - |
Shaman Pharmaceuticals, Inc.
 Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Consejero General | - |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Consejero General | - |
Formación de Carol Zoltowski.
| University of Pennsylvania | Doctorate Degree |
| Seton Hill University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Empresas privadas | 6 |
|---|---|
Shaman Pharmaceuticals, Inc.
Shaman Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shaman Pharmaceuticals, Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements from tropical plant sources. The company was founded by Lisa A. Conte in May 1989 and is headquartered in San Francisco, CA. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Syntex (USA), Inc.
Syntex (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA. | Health Technology |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Carol Zoltowski